Retraction
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2
Paper Information
Record ID:
30325
Journal:
Publication Date:
March 23, 2016
Retraction Date:
June 14, 2021
(4.4 years years ago)
Subjects:
Institution:
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/or.2021.8106Additional Notes:
see also; https://pubpeer.com/publications/5431F6906D8945B0B540811E250F03
Citations (27)
27
Total Citations7
Post-Retraction(25.9%)
20
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
3
After 2+ years
1481
Days since retraction (latest)
Involvement of miR-205-5p in mediating the development of nodular thyroid disease associated with coal worker’s pneumoconiosis via pulmonary extracellular vesicles
Feng Zhao, Hao Yu, Hongzhen Zhang
Frontiers in Endocrinology
Open Access
Published: Jul 2025
1481 days after retraction
Retraction: miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1
Chuntao Li, Zhixiong Liu, Kui Yang et al. (8 authors)
Oncotarget
Open Access
Published: Jan 2024
936 days after retraction
Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1
Ling Xiao, Hui Zhou, Xiangping Li et al. (11 authors)
Oncotarget
Open Access
Published: Jan 2024
936 days after retraction
Retraction: Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1
Hui Li, Guoqing Liu, Ke Pan et al. (5 authors)
Oncotarget
Open Access
Published: Mar 2023
635 days after retraction
Prostate cancer cell‑derived spondin 2 boosts osteogenic factor levels in osteoblasts via the PI3K/AKT/mTOR pathway
Hongbo Wang, Ming Zhang, Wencheng Lu et al. (4 authors)
Oncology Reports
Open Access
Published: Dec 2022
3 citations
3 citations
543 days after retraction
LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway
Yiping Chen, Dongxin Zhang, Qian Cao et al. (4 authors)
Biochemical Genetics
Published: Nov 2022
7 citations
7 citations
523 days after retraction
Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks
Zhimin Yang, Tang Liu, Xiaolei Ren et al. (6 authors)
Cell Cycle
Open Access
Published: Jun 2022
10 citations
10 citations
365 days after retraction
RUNX2 as a promising therapeutic target for malignant tumors
Weizhu Zhao, Haiying Yang, Jie Chai et al. (4 authors)
Cancer Management and Research
Open Access
Published: Mar 2021
26 citations
26 citations
105 days before retraction
miR-205-5p inhibits thymic epithelial cell proliferation via FA2H-TFAP2A feedback regulation in age-associated thymus involution
Bishuang Gong, Xintong Wang, Boning Li et al. (9 authors)
Molecular Immunology
Published: May 2020
14 citations
14 citations
409 days before retraction
<p>circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma</p>
Yupeng Liu, Jun Wan, Long Feng et al. (5 authors)
Cancer Management and Research
Open Access
Published: Feb 2020
32 citations
32 citations
499 days before retraction
The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma
Fernando Alegre, Amanda R. Ormonde, Dayn R. Godinez et al. (6 authors)
Veterinary and Comparative Oncology
Open Access
Published: Aug 2019
8 citations
8 citations
679 days before retraction
miRNA signatures in childhood sarcomas and their clinical implications
G. M. Viera, Karina Bezerra Salomão, Graziella Ribeiro de Sousa et al. (7 authors)
Clinical & Translational Oncology
Published: Apr 2019
15 citations
15 citations
802 days before retraction
MicroRNA‑638 expression change in osteosarcoma patients via PLD1 and VEGF expression
Min Xue, Jinhu Shen, Jie Cui et al. (8 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Mar 2019
10 citations
10 citations
815 days before retraction
The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
Francisco Villanueva, Héctor Araya, Pedro Briceño et al. (17 authors)
Journal of Cellular Physiology
Published: Jan 2019
43 citations
43 citations
883 days before retraction
Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy
Sama Izadpanah, Parastoo Shabani, Ali Aghebati‐Maleki et al. (9 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2019
16 citations
16 citations
887 days before retraction
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti et al. (7 authors)
Expert Review of Molecular Diagnostics
Published: Oct 2018
14 citations
14 citations
972 days before retraction
Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma
Yiqi Deng, Feng Zhao, Zhenhua Zhang et al. (5 authors)
Cancer Biotherapy and Radiopharmaceuticals
Published: Jul 2018
48 citations
48 citations
1070 days before retraction
miR‑205‑5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1
Lianpeng Li, Shouqiang Li
Oncology Letters
Open Access
Published: May 2018
45 citations
45 citations
1110 days before retraction
microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression
Ming Chen, Yongyi Liu, Min‐Qing Zheng et al. (7 authors)
Oncology Letters
Open Access
Published: Mar 2018
9 citations
9 citations
1194 days before retraction
MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
Yuanlong Xie, Wenchao Sun, Zhouming Deng et al. (6 authors)
Scientific Reports
Open Access
Published: Oct 2017
41 citations
41 citations
1342 days before retraction
Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma
Qingbo Li, Xiaohan Pan, Xiqian Wang et al. (7 authors)
Oncotarget
Open Access
Published: Sep 2017
44 citations
44 citations
1377 days before retraction
Paper citing The MicroRNA-217 Functions as a Potential Tumor Su...
Unknown Authors
Unknown Journal
Published: May 2017
1480 days before retraction
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer
Eva Karamitopoulou, Stefan Haemmig, Ulrich Baumgartner et al. (6 authors)
Modern Pathology
Open Access
Published: May 2017
38 citations
38 citations
1480 days before retraction
Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size
David E. Lee, Jacob L. Brown, Megan E. Rosa‐Caldwell et al. (13 authors)
Physiological Genomics
Published: Mar 2017
58 citations
58 citations
1542 days before retraction
What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Gaia Palmini, Francesca Marini, Maria Luisa Brandi
Molecules
Open Access
Published: Mar 2017
66 citations
66 citations
1560 days before retraction
Runx2 expression: A mesenchymal stem marker for cancer
Maria Teresa Valenti, Paola Serafini, Giulio Innamorati et al. (7 authors)
Oncology Letters
Open Access
Published: Sep 2016
28 citations
28 citations
1725 days before retraction
Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma
Zuo-Wei Shi, Jing-Lu Wang, Ning Zhao et al. (5 authors)
Cancer Biomarkers
Published: Aug 2016
20 citations
20 citations
1776 days before retraction
Quick Stats
Total Citations:
27
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025